Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium

Netherlands Heart Journal

Volumn 18, Issue 5, 2010, Pages 236-242

  Ruifrok, W T ^a   Westenbrink, B D ^a   de Boer, R A ^a   den Hamer, I J ^a   Erasmus, M E ^a   Mungroop, H E ^a   Epema, A H ^a   Voors, A A ^a   van veldhuisen, D J ^a   van Gilst, W V ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Apoptosis; Coronary artery bypass; Heart arrest; Heart atria; Heart ventricules; Reperfusion injury

Indexed keywords

EID: 77953241120     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03091769     Document Type: Article

References (28)

1. Alexiou K, Kappert U, Staroske A, Joskowiak D, Wilbring M, Matschke K, et al. Coronary surgery for acute coronary syndrome: which determinants of outcome remain? Clin Res Cardiol. 2008;97:601-8.
2. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res. 2004;61:461-70.
3. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003;42:1075-81.
4. Sugden PH, Clerk A. Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes. Antioxid Redox Signal. 2006;8:2111-24.
5. Sabbah HN, Sharov VG, Goldstein S. Cell death, tissue hypoxia and the progression of heart failure. Heart Fail Rev. 2000;5:131-8.
6. Alexiou K, Kappert U, Staroske A, Joskowiak D, Wilbring M, Matschke K, et al. Coronary surgery for acute coronary syndrome: which determinants of outcome remain? Clin Res Cardiol. 2008;97:601-8.
7. Morariu AM, Loef BG, Aarts LP, Rietman GW, Rakhorst G, van Oeveren W, et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest. 2005;128:2677-87.
8. de Boer RA, van Veldhuisen DJ, van der Wijk J, Brouwer RM, de Jonge N, Cole GM, et al. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Card Fail. 2000;6:330-7.
9. Beller CJ, Horvath E, Kosse J, Becker A, Radovits T, Krempien R, et al. Opposite effects of vascular irradiation on inflammatory response and apoptosis induction in the vessel wall layers via the peroxynitrite-poly(ADP-ribose) polymerase pathway. Clin Res Cardiol. 2007;96:8-16.
10. Fischer UM, Tossios P, Huebner A, Geissler HJ, Bloch W, Mehlhorn U. Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2004;128:103-8.
11. Tossios P, Bloch W, Huebner A, Raji MR, Dodos F, Klass O, et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg. 2003;126:1513-20.
12. Mehlhorn U, Krahwinkel A, Geissler HJ, LaRosee K, Fischer UM, Klass O, et al. Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia. J Thorac Cardiovasc Surg. 2003;125:178-83.
13. Gill C, Mestril R, Samali A. Losing heart: the role of apop-tosis in heart disease-- a novel therapeutic target? FASEB J. 2002;16:135-46.
14. Anselmi A, Abbate A, Girola F, Nasso G, Biondi-Zoccai GG, Possati G, et al. Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg. 2004;25:304-11.
15. Poulsen TD, Andersen LW, Steinbruchel D, Gotze JP, Jorgen-sen OS, Olsen NV. Two Large Preoperative Doses of Erythro-poietin Do Not Reduce the Systemic Inflammatory Response to Cardiac Surgery. J Cardiothorac Vasc Anesth. 2008;23:316-23.
16. Schmitt JP, Schroder J, Schunkert H, Birnbaum DE, Aebert H. Role of apoptosis in myocardial stunning after open heart surgery. Ann Thorac Surg. 2002;73:1229-35.
17. Shalaby A, Rinne T, Jarvinen O, Saraste A, Laurikka J, Porkkala H, et al. Initial results of a clinical study: adenosine enhanced cardioprotection and its effect on cardiomyocytes apoptosis du- ring coronary artery bypass grafting. Eur J Cardiothorac Surg. 2008;33:639-44.
18. Flesch M, Knipp S, Kessler G, Geissler HJ, Massoudy P, Wilhelm H, et al. ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting. Clin Res Cardiol. 2009;98:33-43.
19. Brines M, Cerami A. Emerging biological roles for erythropoi-etin in the nervous system. Nat Rev Neurosci. 2005;6:484-94.
20. Chong ZZ, Kang JQ, Maiese K. Hematopoietic factor erythro-poietin fosters neuroprotection through novel signal transduc-tion cascades. J Cereb Blood Flow Metab. 2002;22:503-14.
21. Chong ZZ, Kang JQ, Maiese K. Angiogenesis and plasticity: role of erythropoietin in vascular systems. J Hematother Stem Cell Res. 2002;11:863-71.
22. Lipsic E, Schoemaker RG, van der Meer P, Voors AA, van Veld-huisen DJ, van Gilst WH. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J Am Coll Cardiol. 2006;48:2161-7.
23. Lipsic E, van der Meer P, Voors AA, Westenbrink BD, van den Heuvel AF, de Boer HC, et al. A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study. Cardiovasc Drugs Ther. 2006;20:135-41.
24. Haljan G, Maitland A, Buchan A, Arora RC, King M, Haigh J, et al. The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS). A Randomized, Double-Blind, Placebo Controlled, Proof-of-Concept Clinical Trial. Stroke. 2009, Epub ahead of print.
25. Chong ZZ, Kang JQ, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation. 2002;106:2973-9.
26. Tramontano AF, Muniyappa R, Black AD, Blendea MC, Cohen I, Deng L, et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun. 2003;308:990-4.
27. Hanlon PR, Fu P, Wright GL, Steenbergen C, Arcasoy MO, Murphy E. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J. 2005;19:1323-5.
28. Bullard AJ, Govewalla P, Yellon DM. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol. 2005;100:397-403.